Aurora Cannabis (ACB) Net Cash Flow Growth (1y) (2018 - 2026)
Aurora Cannabis (ACB) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn | 112.26% |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn | -44.11% |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn | -236.85% |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn | - |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn | 13,485.29% |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn | -1,047.81% |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn | -1,020.00% |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - | - |
| 10 | Aurora Cannabis | 159.37 Mn | 74.12 Mn | 21.72 Mn | -69.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.05% |
| Mar 31, 2025 | 135.33% |
| Dec 31, 2024 | 42.46% |
| Sep 30, 2024 | 22.43% |
| Dec 31, 2023 | 115.42% |
| Sep 30, 2023 | 63.39% |
| Dec 31, 2022 | -935.44% |
| Sep 30, 2022 | 25.27% |
| Jun 30, 2022 | 81.49% |
| Mar 31, 2022 | 16.61% |
| Dec 31, 2021 | -94.93% |
| Sep 30, 2021 | -347.67% |
| Jun 30, 2021 | 55.73% |
| Mar 31, 2021 | 33.37% |
| Dec 31, 2020 | 4,987.37% |
| Sep 30, 2020 | -21.85% |
| Jun 30, 2020 | 88.27% |
| Mar 31, 2020 | -46.78% |
| Dec 31, 2019 | -96.26% |
| Sep 30, 2019 | -110.27% |